Actient Pharmaceuticals, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Actient Pharmaceuticals, LLC - overview
Established
2009
Location
Deerfield, IL, US
Primary Industry
Pharmaceuticals
About
Actient Pharmaceuticals, LLC specializes in pharmaceutical product development, focusing on innovative health solutions for healthcare providers and consumers. The company operates within the pharmaceutical industry, addressing various medical needs through its offerings. Founded in 2009 and headquartered in Deerfield, US, Actient Pharmaceuticals, LLC is engaged in the development of pharmaceutical products. The company underwent a significant business transformation in April 2013 when it was acquired by Auxilium Pharmaceuticals Inc.
for USD 585 mn in an all-cash transaction. Actient has previously completed 2 deals since its inception, indicating a focused approach towards growth and development in the pharmaceutical sector. Actient Pharmaceuticals operates in the pharmaceutical industry, indicated by its domain name, ActientPharma. com, which suggests a focus on pharmaceutical products or services.
While specific product details are not disclosed, the company is implied to develop medications, health supplements, or other health-related products targeting healthcare providers, pharmacies, and consumers across North America, Europe, and parts of Asia. The revenue model for Actient Pharmaceuticals is expected to involve transactions with healthcare providers, pharmacies, and direct-to-consumer sales. Revenue streams may originate from structured sales agreements and bulk purchase deals with healthcare institutions, alongside individual pricing for consumer products. The company's offerings likely cater to specific health needs, establishing revenue through diverse channels.
Actient Pharmaceuticals has positioned itself for future growth following the acquisition by Auxilium in 2013. The funding from this acquisition is expected to facilitate the development and launch of new pharmaceutical products targeted at specific health needs. Additionally, Actient may explore expansion into new markets, potentially focusing on geographical regions with high demand for innovative health solutions, although specific markets and timelines have not been disclosed. The strategic utilization of recent funding will be directed towards enhancing product offerings and market reach.
Primary Industry
Pharmaceuticals
Sub Industries
Specialty Pharmaceuticals
Website
www.actientpharma.com
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Actient Pharmaceuticals, LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Actient Pharmaceuticals, LLC | - | ||||||||
| Add-on | Completed | Striant | - | ||||||||
| Add-on | Completed | Timm Medical Technologies, Inc. | - | ||||||||
| Add-on | Completed | UCB – Six Pharmaceutical Products | - | ||||||||
| Buyout | Completed | Actient Pharmaceuticals, LLC | - |
Displaying 1 - 5 of 5
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.